ENVESTNET ASSET MANAGEMENT INC - BIONDVAX PHARMACEUTICALS LTD ownership

Quarter-by-quarter ownership
ENVESTNET ASSET MANAGEMENT INC ownership history of BIONDVAX PHARMACEUTICALS LTD
ValueSharesWeighting
Q3 2022$58,000
-69.6%
79,216
-51.5%
0.00%
Q2 2022$191,000
+130.1%
163,423
+226.8%
0.00%
Q1 2022$83,000
-29.7%
50,0050.0%0.00%
Q4 2021$118,00050,0050.00%
Other shareholders
BIONDVAX PHARMACEUTICALS LTD shareholders Q4 2022
NameSharesValueWeighting ↓
TRUE Private Wealth Advisors 55,500$64,0000.01%
Aspire Private Capital, LLC 1,600$2,0000.00%
ROYAL BANK OF CANADA 2,540$3,0000.00%
UBS Group AG 4,692$5,0000.00%
CREDIT AGRICOLE S A 4,240$5,0000.00%
WELLS FARGO & COMPANY/MN 200$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 13,768$16,0000.00%
MORGAN STANLEY 33,281$39,0000.00%
Renaissance Technologies 18,300$21,0000.00%
View complete list of BIONDVAX PHARMACEUTICALS LTD shareholders